Spots Global Cancer Trial Database for endometrial carcinoma

Every month we try and update this database with for endometrial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies	NCT02807844	Triple Negative... Pancreatic Carc... Melanoma Endometrial Car...	MCS110 PDR001	18 Years -	Novartis
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate	NCT00483327	Atypical Endome... Endometrial Car...	Megestrol Aceta...	18 Years -	NYU Langone Health
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding	NCT06365905	Endometrial Car...	Non-Interventio...	55 Years -	Mayo Clinic
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers	NCT01523678	Ovarian Cancer Endometrial Can... Uterine Cervica...	Filgrastim Paclitaxel Carboplatin	18 Years -	Belgian Gynaecological Oncology Group
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors	NCT03517488	Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce...	XmAb20717	18 Years -	Xencor, Inc.
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction	NCT01366144	Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc...	Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib	18 Years -	National Cancer Institute (NCI)
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care	NCT03460483	Endometrial Ade... Endometrial Car... Lynch Syndrome Relatives	Genetic Counsel... Genetic Testing Laboratory Biom... Mutation Carrie...	18 Years -	Ohio State University Comprehensive Cancer Center
Targeting Inflammation for Endometrial Cancer Prevention	NCT05407025	Endometrial Car...	Biospecimen Col... Questionnaire A...	18 Years -	Mayo Clinic
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma	NCT00165126	Endometrial Car... Cervix Cancer Carcinoma of th...	Radiation thera...	18 Years - 90 Years	Dana-Farber Cancer Institute
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer	NCT06253494	Endometrial Can... Cancer of Endom... Carcinoma of En... Endometrial Car...	AdHER2DC vaccin... Pembrolizumab N-803 Lenvatinib PATHWAY HER2 (4...	18 Years - 120 Years	National Institutes of Health Clinical Center (CC)
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer	NCT02635672	Neoplasms	VIP152 (BAY 125... VIP152 (BAY 125... Keytruda VIP152 (BAY 125...	18 Years -	Vincerx Pharma, Inc.
Targeting Inflammation for Endometrial Cancer Prevention	NCT05407025	Endometrial Car...	Biospecimen Col... Questionnaire A...	18 Years -	Mayo Clinic
GEN1046 Safety Trial in Patients With Malignant Solid Tumors	NCT03917381	Solid Tumors Non-small Cell ... Urothelial Carc... Endometrial Car... Triple Negative... Squamous Cell C... Cervical Cancer	Acasunlimab Acasunlimab in ... Acasunlimab in ... Acasunlimab in ...	18 Years -	Genmab
Improved Method of Detecting Cancer Metastases	NCT02368067	Endometrial Car...	Standard of Car... Study Sentinal ...	18 Years -	Southeastern Regional Medical Center
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer	NCT02635672	Neoplasms	VIP152 (BAY 125... VIP152 (BAY 125... Keytruda VIP152 (BAY 125...	18 Years -	Vincerx Pharma, Inc.
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer	NCT03015129	Endometrial Can... Endometrial Car... Endometrial Car... Endometrial Can... Endometrial Car...	Durvalumab Tremelimumab	18 Years -	Memorial Sloan Kettering Cancer Center
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors	NCT05067972	Ovarian Neoplas... Endometrial Neo... Breast Neoplasm...	PF-07260437 B7-H4 IHC	18 Years -	Pfizer
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss	NCT03027479	Weight Loss Ovarian Carcino... Endometrial Car...	Samples	18 Years -	University Hospital, Tours
A Study of SGN-B7H4V in Advanced Solid Tumors	NCT05194072	Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... Triple Negative... HER2 Negative B... Hormone Recepto... Endometrial Neo... Carcinoma, Non-... Cholangiocarcin... Gallbladder Car... Adenoid Cystic ...	SGN-B7H4V	18 Years -	Seagen Inc.
A Study of Nivolumab in Selected Uterine Cancer Patients	NCT03241745	Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc...	Nivolumab	18 Years -	Memorial Sloan Kettering Cancer Center
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	NCT05950464	Endometrial Car... Endometrial Cle... Endometrial End... Endometrial Low... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Low Gra... Platinum-Resist...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Electrocardiogr... Magnetic Resona... Tuvusertib X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma	NCT00165126	Endometrial Car... Cervix Cancer Carcinoma of th...	Radiation thera...	18 Years - 90 Years	Dana-Farber Cancer Institute
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care	NCT03460483	Endometrial Ade... Endometrial Car... Lynch Syndrome Relatives	Genetic Counsel... Genetic Testing Laboratory Biom... Mutation Carrie...	18 Years -	Ohio State University Comprehensive Cancer Center
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy	NCT04713618	Anal Carcinoma Cervical Carcin... Endometrial Car... Malignant Pelvi... Rectal Carcinom... Vaginal Carcino... Vulvar Carcinom...	Pelvic Examinat... Survey	18 Years -	Ohio State University Comprehensive Cancer Center
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors	NCT02611024	Advanced Solid ... Glioblastoma Soft Tissue Sar... Endometrial Car... Epithelial Ovar... Mesothelioma Gastroenteropan... SCLC Gastric Carcino... Pancreatic Aden... Colorectal Carc... Neuroendocrine ...	Lurbinectedin Irinotecan	18 Years -	PharmaMar
Complications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial Carcinoma	NCT04894552	Laparoscopic Hy...	Laparoscopic Hy...	18 Years - 100 Years	Ain Shams Maternity Hospital
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss	NCT03027479	Weight Loss Ovarian Carcino... Endometrial Car...	Samples	18 Years -	University Hospital, Tours
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors	NCT03372720	Cervical Carcin... Dyspareunia Endometrial Car... Ovarian Carcino... Vaginal Carcino... Vaginal Dryness Vulvar Carcinom...	Laser Therapy Questionnaire A... Sham Interventi...	-	Ohio State University Comprehensive Cancer Center
Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development	NCT05914844	Endometrial Can...		-	Celal Bayar University
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors	NCT03006887	Solid Tumors	lenvatinib pembrolizumab	20 Years -	Eisai Inc.
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
A Beta-only IL-2 ImmunoTherapY Study	NCT05086692	Advanced Solid ... Unresectable So... Clear Cell Rena... Triple Negative... Non-Small Cell ... Non-Small Cell ... Colorectal Canc... Gastric Cancer Cervical Cancer Basal Cell Carc... Bladder Cancer Merkel Cell Car... Squamous Cell C... Cutaneous Squam... Pleural Mesothe... Esophageal Canc... Endometrial Car... Solid Tumor Solid Tumor, Ad... MSI-H Solid Mal... Cancer With A H... Epithelial Ovar... Primary Periton... Gastroesophagea... Acral Melanoma Mucosal Melanom... Cutaneous Melan... DMMR Solid Mali... Fallopian Tube ... Ovarian Cancer MSI-H Cancer DMMR Cancer Pancreas Adenoc... Skin Cancer	MDNA11 Pembrolizumab	18 Years -	Medicenna Therapeutics, Inc.
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies	NCT00315861	Ovarian Cancer Endometrial Can... Cervical Cancer Lung Cancer	pemetrexed topotecan	18 Years -	SCRI Development Innovations, LLC
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies	NCT05803018	Gynecological M... Solid Tumor	BL-B01D1	18 Years - 75 Years	Sichuan Baili Pharmaceutical Co., Ltd.
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding	NCT06365905	Endometrial Car...	Non-Interventio...	55 Years -	Mayo Clinic
Letrozole as a Treatment of Endometrial Cancer	NCT00997373	Endometrial Car...	Letrozole	40 Years -	University of California, Davis
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies	NCT02807844	Triple Negative... Pancreatic Carc... Melanoma Endometrial Car...	MCS110 PDR001	18 Years -	Novartis
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer	NCT05647109	Endometrial Car... Atypical Endome...	No intervention	17 Years - 45 Years	Peking University People's Hospital
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma	NCT05036681	Metastatic Canc... Endometrium Can... Endometrial Car...	Futibatinib Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Incidence of Malignant and Premalignant Endometrial Polyp in Asymptomatic and Symptomatic Postmenopausal Women	NCT01203176	Endometrial Pol... Malignant and P...	Hysteroscopic p...	18 Years - 80 Years	Carmel Medical Center
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma	NCT01454479	Recurrent Endom...	Lapatinib and i...	20 Years - 75 Years	Chang Gung Memorial Hospital
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma	NCT04080284	Endometrial Can... Papillary Serou... Uterine Serous ... Endometrial Car... Cancer of the E...	Niraparib	18 Years -	Northwell Health
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy	NCT03671811	Atypical Endome... Endometrial Car...	Megestrol Aceta... Pterostilbene	18 Years -	City of Hope Medical Center
Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development	NCT05914844	Endometrial Can...		-	Celal Bayar University
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma	NCT04716686	Endometrial Car... Serous Carcinom...	Niraparib	18 Years -	Shandong University
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors	NCT04634617	Endometrial Car... Malignant Uteri... Uterine Corpus ... Uterine Corpus ...	Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors	NCT02465541	Obesity Endometrial Car...	Gentle yoga the... counseling inte... educational int... quality-of-life... questionnaire a...	-	Ohio State University Comprehensive Cancer Center
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer	NCT04567771	Cervical Carcin... Endometrial Car... Endometriosis Pelvic Inflamma...	Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	Mayo Clinic
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma	NCT05036681	Metastatic Canc... Endometrium Can... Endometrial Car...	Futibatinib Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma	NCT02017353	Endometrial Car...	Curcuphyt	18 Years -	University Hospital, Gasthuisberg
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer	NCT00879359	Endometrial Car...	carboplatin, pa...	18 Years -	The Cleveland Clinic
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies	NCT04152499	Epithelial Ovar... Gastric Adenoca... Gastroesophagea... Urothelial Carc... Non-Small Cell ... Small-Cell Lung... Endometrial Car... Head and Neck S... Breast Cancer	SKB264	18 Years - 75 Years	Klus Pharma Inc.
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors	NCT00756847	Cancer Non-Small Cell ... Endometrial Car... Ovarian Carcino...	XL147 (SAR24540... paclitaxel carboplatin	18 Years -	Sanofi
A Study Evaluating MM-310 in Patients With Solid Tumors	NCT03076372	Solid Tumors Urothelial Carc... Gastric Carcino... Squamous Cell C... Ovarian Cancer Pancreatic Duct... Prostate Adenoc... Non-small Cell ... Small Cell Lung... Triple Negative... Endometrial Car... Soft Tissue Sar...	MM-310	18 Years -	Merrimack Pharmaceuticals
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer	NCT06413992	Endometrial Car... TP53 Mutation Recurrent or Me...	Fluzoparib Camrelizumab paclitaxel (alb... Carboplatin inj... Carboplatin External irradi...	18 Years -	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma	NCT01455493	Endometrial Car...	GDC-0980	18 Years -	Genentech, Inc.
Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery	NCT01562106	Endometrial Can...	Fluorescence-gu...	18 Years -	Swedish Medical Center
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab	NCT04652076	Endometrial Car... Cervix Carcinom...	NP137 Pembrolizumab Paclitaxel Carboplatin	18 Years -	NETRIS Pharma
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma	NCT01454479	Recurrent Endom...	Lapatinib and i...	20 Years - 75 Years	Chang Gung Memorial Hospital
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer	NCT02983279	Breast Carcinom... Endometrial Car... Prostate Carcin...	Dietary Interve... Counseling Therapeutic	18 Years -	Thomas Jefferson University
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery	NCT04224467	Cervical Cancer Ovarian Tumor Endometrial Car... Uterine Myomato... Adenomyosis Ovarian Cyst Be... Ovarian Cyst Ma... Endometriosis Uterine Sarcoma	Intravenous ICG...	18 Years - 80 Years	Southern Medical University, China
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies	NCT02025985	Ovarian Carcino... Endometrial Car... Cervical Carcin...	Selinexor	18 Years -	Karyopharm Therapeutics Inc
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer	NCT02635672	Neoplasms	VIP152 (BAY 125... VIP152 (BAY 125... Keytruda VIP152 (BAY 125...	18 Years -	Vincerx Pharma, Inc.
Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach	NCT05894915	Endometrial Car... Tumor Molecular...	open surgery laparoscopic su...	40 Years - 80 Years	Peking University People's Hospital
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma	NCT05316467	Endometrial Car... Obese Overweight Fertility Issue...	Intensive Lifes... Megestrol Aceta...	18 Years - 45 Years	Fudan University
The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma	NCT03877627	Endometrial Car... Lymphadenectomy	Pelvic and Peri...	10 Years - 90 Years	Second Affiliated Hospital of Wenzhou Medical University
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique	NCT03766672	Endometrial Neo...	Intervention Ar...	-	University Hospital Center of Martinique
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	NCT02465060	Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ...	Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib	18 Years -	National Cancer Institute (NCI)
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer	NCT03015129	Endometrial Can... Endometrial Car... Endometrial Car... Endometrial Can... Endometrial Car...	Durvalumab Tremelimumab	18 Years -	Memorial Sloan Kettering Cancer Center
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies	NCT00315861	Ovarian Cancer Endometrial Can... Cervical Cancer Lung Cancer	pemetrexed topotecan	18 Years -	SCRI Development Innovations, LLC
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma	NCT01460979	Genital Disease... Ovarian Disease... Ovarian Neoplas... Endometrial Neo...	Temsirolimus	18 Years -	AGO Study Group
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer	NCT06413992	Endometrial Car... TP53 Mutation Recurrent or Me...	Fluzoparib Camrelizumab paclitaxel (alb... Carboplatin inj... Carboplatin External irradi...	18 Years -	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors	NCT03006887	Solid Tumors	lenvatinib pembrolizumab	20 Years -	Eisai Inc.
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives	NCT04257045	Breast Carcinom... Deleterious CDH... Deleterious DIC... Deleterious SMA... Deleterious STK... Endometrial Car... Fallopian Tube ... Ovarian Carcino... Primary Periton...	Interview Questionnaire A... Survey Administ...	18 Years -	M.D. Anderson Cancer Center
Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery	NCT01562106	Endometrial Can...	Fluorescence-gu...	18 Years -	Swedish Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: